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Abstract. 
 
Expression cloning from a cDNA library pre-
pared from a mutant CHO cell line with Golgi-speciﬁc 
resistance to Brefeldin A (BFA) identiﬁed a novel 206-
kD protein with a Sec7 domain termed GBF1 for Golgi 
BFA resistance factor 1. Overexpression of GBF1 al-
lowed transfected cells to maintain normal Golgi mor-
phology and grow in the presence of BFA. Golgi-
enriched membrane fractions from such transfected 
cells displayed normal levels of ADP ribosylation fac-
tors (ARFs) activation and coat protein recruitment 
that were, however, BFA resistant. Hexahistidine-
tagged–GBF1 exhibited BFA-resistant guanine nucle-
otide exchange activity that appears speciﬁc towards 
 
ARF5 at physiological Mg
 
2
 
1
 
concentration. Character-
ization of cDNAs recovered from the mutant and wild-
type parental lines established that transcripts in these 
cells had identical sequence and, therefore, that GBF1 
was naturally BFA resistant. GBF1 was primarily cyto-
solic but a signiﬁcant pool colocalized to a perinuclear 
 
structure with the 
 
b
 
-subunit of COPI. Immunogold la-
beling showed highest density of GBF1 over Golgi cis-
ternae and signiﬁcant labeling over pleiomorphic 
smooth vesiculotubular structures. The BFA-resistant 
nature of GBF1 suggests involvement in retrograde 
trafﬁc.
Key words: Golgi complex • Brefeldin A • Sec7 • 
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B
 
REFELDIN
 
 A (BFA)
 
1
 
 is a small fungal heterocyclic
lactone that blocks protein secretion (Misumi et al.,
1986) and induces rapid and profound morpholog-
ical changes in several organelles of the secretory pathway.
In most cell types, BFA causes disassembly of the Golgi
complex and redistribution of Golgi resident enzymes into
the ER (Klausner et al., 1992; Pelham, 1991).
The earliest documented step in BFA action is inhibi-
tion of the recruitment of members of the ADP-ribosyla-
tion factor (ARF) family of GTPases onto membranes
(Donaldson et al., 1992b; Helms and Rothman, 1992; Ran-
dazzo et al., 1993). The binding of ARFs to membranes is
believed to provide high affinity binding sites for the Golgi
coat protein COPI (Rothman and Orci, 1996). This preas-
sembled complex of seven polypeptides is recruited to the
membrane, initiating vesicle budding. In addition, the ob-
servation that ARFs stimulate phospholipase D activity on
Golgi membranes (Brown et al., 1995; Ktistakis et al.,
1996) suggests that ARFs may induce remodeling of the
membranes by increasing the local levels of acidic phos-
pholipids, which in turn may modulate recruitment of coat
proteins (for review see Roth and Sternweis, 1997). Inhibi-
tion of ARF recruitment onto Golgi membranes, thus,
prevents the assembly of the COPI complex and readily
explains the effects of BFA on the secretory apparatus.
The observation that BFA interferes with the recruitment
of other proteins such as the Golgi-specific clathrin adap-
tors AP1 (Stamnes and Rothman, 1993; Traub et al., 1993)
suggests the blocking of ARF-dependent recruitment of
coat proteins as a general mechanism to explain the effects
of BFA on all affected organelles.
BFA interferes with ARF recruitment by blocking the
exchange of GTP for GDP, thereby preventing a confor-
mational switch required for their association with Golgi
membranes (Donaldson et al., 1992b; Helms and Roth-
man, 1992; Randazzo et al., 1993; Franco et al., 1995, 1996;
Antonny et al., 1997; Losonczi and Prestegard, 1998). This
exchange reaction is catalyzed by a membrane-associated
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guanine nucleotide exchange factor (GEF) that resists ex-
traction with 1 M KCl and is protease sensitive (Donald-
son et al., 1992b; Helms and Rothman, 1992; Randazzo et al.,
1993). A BFA-sensitive exchange activity has also been
detected in a large (
 
.
 
700 kD) soluble complex (Tsai et al.,
1994; Morinaga et al., 1996), indicating that ARF-specific
guanine nucleotide exchange activities (ARF-GEFs) may
exist in dynamic equilibrium between membrane-bound
and soluble pools.
We previously isolated several CHO mutant lines able
to grow in the presence of BFA (Yan et al., 1994). Further
characterization revealed that all of our mutant lines,
termed BFY, had acquired Golgi-specific resistance. For
example, whereas Golgi morphology and function became
resistant to BFA in BFY cells, early endosomes retained
their characteristic sensitivity (Yan et al., 1994). A similar
study with an independently obtained collection of BFA-
resistant CHO lines led to an identical conclusion (Torii
et al., 1995). These results indicate that BFA acts by alter-
ing the function of related but distinct organelle specific
targets that can be independently mutagenized and identi-
fied. In addition, they suggested that further analysis of
BFY cells should identify a Golgi-specific BFA target.
Recently, a novel family of proteins implicated in ARF
activation has been found to share the central domain of
Sec7p (Sec7d). ARF-GEF activity was first reported for
ARNO and Gea1p (Chardin et al., 1996; Peyroche et al.,
1996). In addition, p200/ARF-GEP, a member of a large
complex identified on the basis of its GEF activity, was
subsequently shown to contain a Sec7d (Morinaga et al.,
1996, 1997). The defining 170 residue Sec7d is highly con-
served among the various members and was shown to
have intrinsic ARF-GEF activity (Chardin et al., 1996;
Sata et al., 1998; Mansour et al., 1999). Structural studies
with the Sec7d of ARNO and GEA2p identified a critical
glutamate residue that penetrates in the GTPase active
site of ARFs to perturb Mg
 
2
 
1
 
 binding and promote disso-
ciation of the guanine nucleotide (Beraud-Dufour et al.,
1998; Goldberg, 1998). This domain appears to be a direct
target of BFA since the ARF-GEF activity of purified
Sec7d from several proteins is sensitive to BFA (Sata et al.,
1998; Mansour et al., 1999). Furthermore, mutations of
key residues in this domain can dramatically alter its BFA
sensitivity (Peyroche et al., 1999).
The various members of the Sec7d family likely act on
different organelles and play distinct roles in protein traf-
fic. To identify those members or their upstream regula-
tors implicated in Golgi function, we used expression clon-
ing to recover proteins relevant to growth inhibition by
BFA. Here, we report the cloning and characterization of
a novel Sec7d protein from a cDNA library prepared from
one of our most resistant BFY lines. This 206-kD protein
contains a Sec7 domain, localizes to the Golgi complex,
and demonstrates BFA-resistant GEF activity that ap-
pears specific towards ARF5 at physiological Mg
 
2
 
1
 
 con-
centration.
 
Materials and Methods
 
Reagents
 
ATP, UTP, creatine phosphate, and rabbit creatine phosphokinase were
 
purchased from Boehringer Mannheim Biochemicals. Unless otherwise
indicated, all other chemicals were obtained from Sigma Chemical Co.
BFA was stored at 
 
2
 
20ºC as a stock solution of 10 mg/ml (36 mM) in ei-
ther 100% ethanol or DMSO. DNA and RNA purification kits and Ni-
NTA resin were purchased from Qiagen. cDNA preparation kits were
from GIBCO BRL. Restriction enzymes, T4 DNA ligase, alkaline phos-
phatase, linker-adaptors, 
 
Taq
 
, and Klenow DNA polymerases were from
New England BioLabs Inc. The pCEP4, pRSETA, and pEBVHis-C
plasmids and the TOP10 
 
Escherichia coli
 
 strain were from Invitrogen
Corp. Protein quantitation reagents and protein size markers were from
Bio-Rad Laboratories. The radioactive nucleotides 
 
a
 
[
 
32
 
P]GTP and
 
g
 
[
 
35
 
S]GTP
 
g
 
S were from NEN. Nitrocellulose membranes and filters were
from MSI.
 
Tissue Culture
 
Media, culture reagents, Lipofectamine, and hygromycin B were pur-
chased from Life Technologies Inc. Disposable plasticware and culture
dishes were purchased from Falcon. The CHO
 
pro-5
 
 and 293-EBNA cell
lines were purchased from American Type Culture Collection and Invi-
trogen Corp., respectively. The isolation of BFY-1 from the parental
CHO
 
pro-5 
 
line was previously described (Yan et al., 1994). Normal rat kid-
ney (NRK) cells were obtained from Dr. Thomas Hobman (University of
Alberta, Edmonton, Alberta, Canada). The CHO
 
pro-5
 
 and BFY-1 mutant
lines were maintained in suspension in 
 
a
 
-MEM (GIBCO BRL) supple-
mented with 7.5% FCS (Sigma Chemical Co.), 100 
 
m
 
g/ml penicillin G, and
100 
 
m
 
g/ml streptomycin. Monolayers of 293-EBNA and NRK cells were
maintained in DME supplemented with 10% FCS, 100 
 
m
 
g/ml penicillin G,
and 100 
 
m
 
g/ml streptomycin.
 
Antibodies
 
The m3A5 mouse mAb that recognizes the 110-kD 
 
b
 
-COP subunit and
the antigiantin serum were supplied by the late Dr. Thomas Kreis (Uni-
versity of Geneva, Geneva, Switzerland) and Dr. E. Chan (Scripps Insti-
tute, La Jolla, CA), respectively. Rabbit anti–mouse IgG was obtained
from Boehringer Mannheim Biochemicals. HRP-conjugated goat anti–
mouse and anti–rabbit IgG were obtained from Bio-Rad Laboratories and
Amersham Life Science, Inc., respectively. FITC-conjugated donkey anti–
mouse and Texas red–conjugated donkey anti–rabbit antibodies were
from Jackson ImmunoResearch Laboratories, Inc. Goat anti–rabbit IgG-
10 nm gold was from Sigma Chemical Co.
The peptide TDPIPTSEVN that corresponds to the carboxy-terminal
sequence of Golgi-specific Brefeldin A resistance factor (GBF) 1 was syn-
thesized by the Alberta Peptide Institute (University of Alberta) and
cross-linked to keyhole limpet hemocyanin (KLH) or BSA. Female New
Zealand rabbits were immunized using 200 
 
m
 
g of KLH-linked peptide
emulsified 1:1 with Freund’s complete adjuvant (Sigma Chemical Co.) and
injected subcutaneously or intramuscularly in four sites (0.25 ml/site).
Booster immunizations using 100 
 
m
 
g of KLH-linked peptide emulsified 1:1
with Freund’s incomplete adjuvant were performed subcutaneously every
4 wk. Serum from rabbits H133, H134, and H154 displayed high titer and
specificity by immunoblot analysis. Serum H133 was best for immunoelec-
tron microscopy studies, whereas serum H154 was chosen for indirect im-
munofluorescence studies (Harlow and Lane, 1988).
 
Immunoblots
 
Immunoblots were carried out essentially as described (Harlow and Lane,
1988). For determination of 
 
b
 
-COP levels, proteins transferred to nitro-
cellulose were probed with mAb m3A5 and detected by the enhanced
chemiluminescence method using HRP-conjugated goat anti–mouse IgG.
The results were quantitated using a scanner (Microtek E6). GBF1 levels
were measured using the enhanced chemifluorescence method (Amer-
sham) and a Storm (Molecular Dynamics, Inc.) fluorimetric scanner as per
the manufacturer’s instructions. Results were quantitated using the Image-
Quant software program (Molecular Dynamics, Inc.).
 
Preparation of Subcellular Fractions
 
CHO cells grown in suspension were homogenized by repeated passage
though the narrow bore of a ball homogenizer (Balch and Rothman,
1985). For preparation of homogenates, cells grown as monolayers were
washed once in cold PBS before recovery by scraping into PBS containing
1 mM EDTA. Cells were washed once in buffer H (0.25 M sucrose/10 mM
Tris, pH 8) and homogenized in the same buffer by 12 slow passages 
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through a 23-gauge needle. In all cases homogenization buffer was supple-
mented with 1 mM PMSF and the recommended concentrations of anti-
pain, pepstatin, leupeptin, aprotinin, and E-64. Postnuclear supernatants
were prepared by centrifugation of crude homogenates at 1,000 
 
g
 
 for 10
min. Cytosols were prepared by desalting high speed (100,000 
 
g
 
) superna-
tants of crude homogenates over P6-DG (Bio-Rad Laboratories). Golgi-
enriched membranes were obtained from crude homogenates by float-up
on discontinuous sucrose density gradients as described (Balch et al.,
1984).
To determine the distribution of GBF1, postnuclear supernatants (400
 
m
 
g protein) were adjusted to 130 
 
m
 
l and spun at 100,000 
 
g
 
 for 8 min in a
Beckman TLA 100.2 rotor. After recovery of supernatants, pellets were
washed with 3 ml buffer H and spun again. Washed microsomal pellets
were resuspended in 120 
 
m
 
l buffer H containing 1% Triton X-100. Super-
natants were adjusted to contain 1% Triton X-100 and 30 
 
m
 
l of each frac-
tion were analyzed by immunoblots.
Detergent extracts were prepared either by incubating washed 150 cm
 
2
 
monolayers with 2.5 ml ice-cold lysis buffer (50 mM Tris, pH 7.5, 150 mM
NaCl, 0.5% Triton X-100, 1 mM PMSF, and protease inhibitors), or by re-
suspending washed cell pellets in 4 vol lysis buffer. After 5 min on ice, the
lysed cells were passed 10 times through a 23-gauge needle and spun 10
min at 1,000 
 
g
 
 at 4
 
8
 
C. Supernatants were stored at 
 
2
 
70
 
8
 
C.
 
Purification of Native Bovine Brain ARFs
 
Partially purified ARFs were prepared from brain extracts using methods
adapted from Taylor et al. (1992). In brief, bovine brain extracts were pre-
pared from frozen brains (Pel-Freez; Rogers) and subjected to precipita-
tion with ammonium sulfate. The protein pellet was resuspended in HKM
buffer (25 mM Hepes, pH 7.1, 50 mM KCl, 1 mM MgCl
 
2
 
) and desalted
over a P6-DG column equilibrated in TM buffer (10 mM Tris, pH 7.9, 1 mM
MgCl
 
2
 
) containing 50 mM KCl. The eluate was adjusted with TM buffer to
give a conductivity equivalent to 50 mM KCl before loading onto a Q-Seph-
arose (Pharmacia) column. The flowthrough from the Q-Sepharose col-
umn was adjusted with TM buffer to a conductivity equivalent to 20 mM
KCl and run again over Q-Sepharose to allow ARF binding. ARFs were
released with 50 mM KCl buffer and the eluate was concentrated by ultra-
filtration over a YM10 membrane (Amicon). The concentrated sample
was loaded onto a HiLoad 16/60 Superdex-75 column (Pharmacia) and
ARF-containing fractions were eluted in 10 mM Tris, pH 8.0, 50 mM KCl,
1 mM MgCl
 
2
 
 and 10% glycerol. ARF fractions were identified using
GTP–ligand blots (see above). The purity of pooled ARF fractions was es-
timated at 30% on the basis of its specific activity in GTP–ligand blots, us-
ing pure bovine ARF1 as standard. ARF1 and ARF3 were fully myristoy-
lated and present at a ratio of 1:9, as determined by HPLC and mass
spectrometry.
 
Purification of Recombinant Myristoylated ARF5
 
Cultures of BL21(DE3) harboring plasmids encoding human ARF5
(ARF5:PET21d
 
1
 
; Berger et al., 1998) and yeast 
 
N
 
-myristoyl transferase
(pBB131; Duronio et al., 1990) containing 100 
 
m
 
g/ml ampicillin and 20 
 
m
 
g/ml
kanamycin were induced by addition of IPTG (0.5 mM) at an OD
 
600
 
 of
0.8. Bacteria were harvested by centrifugation after 4 h of growth at ambi-
ent temperature. The bacterial pellet was resuspended in 4 vol of lysis
buffer (50 mM Hepes, pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.02%
Na
 
1
 
azide) and supplemented with chicken egg lysozyme (1 mg/ml). After
30–60 min on ice, bacteria were passed three times through a French press
in a chilled 1-inch cell (model FA-073; SLM/Aminco) and cellular debris
were removed by centrifugation (10,000 
 
g
 
, 30 min, 4
 
8
 
C). ARFs were pre-
cipitated at 4
 
8
 
C by gradual addition of ammonium sulfate up to 40% satu-
ration (at 0
 
8
 
C). Protein pellets were back extracted with 50 ml 10 mM Tris,
pH 8, 1 mM MgCl
 
2
 
 for 2 h. The solubilized protein fractions (
 
z
 
52 ml) were
desalted on a Bio-Gel P-6 DG (Bio-Rad Laboratories) column (450 ml,
2.6 
 
3
 
 89 cm), equilibrated in desalting buffer (10 mM Tris, pH 8.0 at 4
 
8
 
C,
50 mM KCl, 1 mM MgCl
 
2
 
) at 0.4 ml/min, and fractions containing protein
were pooled for anion exchange chromatography. This desalted fraction
was diluted with desalting buffer without KCl to a final conductivity at or
below that of a 25-mM KCl standard, and then loaded onto a 175-ml
Q-Sepharose fast flow column (FFQ; Pharmacia) equilibrated in desalting
buffer with 25 mM KCl. ARF5 was eluted with a single-step gradient of
10 mM Tris, pH 8, 120 mM KCl, 1 mM MgCl
 
2
 
.
The eluate was concentrated 10-fold over a YM10 membrane and the
salt was adjusted to 60 mM using buffer exchange. The concentrated pro-
tein fraction was cleared by centrifugation before size exclusion chroma-
tography on a Superdex 75 column (Pharmacia HiLoad 16/60 Prep Grade)
 
equilibrated in desalting buffer with 10% glycerol. The major ARF-con-
taining fractions were identified by SDS-PAGE and Coomassie staining,
pooled, flash frozen, and stored at 
 
2
 
70
 
8
 
C. HPLC analysis established that
purity and extent of myristoylation were 
 
.
 
90%.
 
Measurement of Membrane-associated Guanine 
Nucleotide Exchange Activity
 
ARF-GEF was measured using a filtration method adapted from the as-
say developed by Donaldson et al. (1992a). In brief, incubations were car-
ried out in a 100-
 
m
 
l reaction mixture containing 25 mM Hepes, pH 8.0,
25 mM KCl, 2.5 mM MgCl
 
2
 
, 1 mM DTT, 1 mM ATP, 10 
 
m
 
g BSA, 0.2 M
sucrose, 1 
 
m
 
M 
 
a
 
[
 
32
 
P]GTP (1–2 
 
3
 
 10
 
4
 
 cpm/pmol), 5.5 
 
m
 
g of semi-purified
ARF proteins (
 
z
 
30% pure) and 4 
 
m
 
g of Golgi-enriched membranes in the
presence or absence of BFA at 37
 
8
 
C for 1 h. The reaction was terminated
by the addition of 2 ml cold 10 mM Hepes, pH 8.0, and the amount of pro-
tein-bound nucleotide was determined by filtration through nitrocellulose
filters followed by five 2-ml washes with cold 10 mM Hepes, pH 8.0, solu-
tion. The extent of membrane-dependent nucleotide exchange occurring
on ARFs specifically was calculated by correcting the signal from com-
plete reactions, using background values measured in control incubations
lacking ARFs or membranes. The membranes and ARF-independent
nonspecific exchange corresponded to 
 
z
 
20–35% of the signal observed
with complete reaction. BFA affected nonspecific nucleotide exchange by
only 
 
z
 
5%, irrespective of which Golgi membranes were used. The Golgi
extracts were normalized by protein concentration and UDP–galactosyl
transferase activity (data not shown).
 
Measurement of Coatomer Recruitment 
 
Assays were carried out as previously described (Yan et al., 1994). Each
200-
 
m
 
l coatomer binding assay contained 10 
 
m
 
g of Golgi-enriched mem-
brane fractions prepared from BFA-sensitive 293 or from 293 cells over-
expressing GBF1 and 90 
 
m
 
g of cytosol prepared from BFA-sensitive
CHO
 
pro-5
 
 cells. After a 20-min incubation at 30
 
8
 
C in the presence of the in-
dicated BFA concentrations, membranes were collected by centrifugation
and resuspended in SDS sample buffer. The complete sample was loaded
on 10% SDS gel and the relative amounts of membrane-associated
 
b
 
-COP were determined using immunoblotting as described above.
 
cDNA Library Preparation
 
Total RNA was extracted from 10
 
8
 
 cells of the BFY-1 line and the paren-
tal line (CHO
 
pro-5
 
) from which they were derived. Poly (A)
 
1
 
 mRNA was
purified over oligo-dT columns (Life Technologies) and used for cDNA
synthesis according to the manufacturer’s instructions (Superscript II; Life
Technologies, Inc.). First-strand synthesis was primed using the provided
oligo-dT/NotI primer-adapter, and a partially duplex HindIII primer with
5
 
9 
 
overhang (pAGCTCGAAGGGGTTCG; New England Biolabs) was
blunt-end ligated to cDNAs after second-strand synthesis. Size analysis
revealed cDNAs up to 20 kb in length, with the range of 0.5–11 kb well
represented in both libraries. cDNAs were digested with NotI and ligated
to the pCEP4 vector (digested with HindIII and NotI). The resulting li-
braries were transformed in 
 
E
 
.
 
 coli 
 
TOP10 and displayed on plates. At
least 2.5 
 
3
 
 10
 
5
 
 colonies for each library were grown on Luria-Bertani me-
dium (LB) plates, harvested, pooled, and stored in aliquots at 
 
2
 
70
 
8
 
C.
 
Library Selection
 
Library aliquots were thawed and added to 1.5 liters of warm LB media
and grown to a final OD
 
600
 
 of 0.4 (two to three generations). Plasmid
DNA was isolated using a maxiprep kit (Qiagen). 293-EBNA cells were
grown in T-175 flasks to 
 
z
 
60% density and transformed with 10 
 
m
 
g of the
above libraries and 240 
 
m
 
g of Lipofectamine per flask, following the man-
ufacturer’s instructions. FCS was added after 6 h to 10% final concentra-
tion and the cells were further incubated for 18 h. The medium was re-
placed with complete DME containing 0.3 mg/ml hygromycin B and cells
were cultured for 36 h to select transformants. At the end of this incuba-
tion, loose cells were removed and survivors were trypsinized and trans-
ferred to new flasks with complete DME containing 0.3 mg/ml hygromy-
cin B. After 24 h, the hygromycin-sensitive cells that failed to reattach
were removed and the surviving successful transformants (10–20% of ini-
tial population) were recovered by trypsinization. These cells were plated
on Primaria dishes (Falcon) in complete DME with 0.3 mg/ml hygromycin
B plus 0.4 
 
m
 
M BFA to select BFA-resistant transformants. The medium 
The Journal of Cell Biology, Volume 146, 1999 74
 
was replaced every 24–36 h and BFA pressure was maintained until no
survivors remained among control cells transformed in parallel with
empty vector. At this point (usually 7–10 d), the BFA concentration was
reduced to 0.2 
 
m
 
M and small colonies were allowed to grow for 2 wk. Sur-
viving colonies were pooled and the plasmid DNA was recovered (Hirt,
1967). This DNA was electroporated in 
 
E
 
.
 
 coli
 
, the successful transfor-
mants were pooled, expanded in liquid culture, and plasmid DNA recov-
ered by Midiprep (Qiagen). This enriched library was used in a new round
of selection using the procedure described above. Since this expression
system allows 50 episomes to be stably maintained per cell, the clone re-
sponsible for BFA resistance could be at best present at a frequency of 1
in 50 and could not be directly isolated by this methodology.
After two enrichment cycles, the recovered plasmids were electropo-
rated in 
 
E
 
.
 
 coli
 
, and 100 colonies were selected at random and individually
grown. Restriction analysis of miniprep DNA recovered from these clones
showed that 33 contained inserts larger than 1 kb. Transformation of these
plasmids into 293-EBNA cells, first in pools and then individually (diluted
50 times with empty vector), identified one plasmid, clone 32, that was
able to confer BFA resistance. Dilution of clone 32 with empty pCEP4
was essential since transformation with pure clone 32 caused rapid death
of the transformed cells. Dilution in the range between 5 to 50-fold ap-
peared optimal since larger dilution caused a substantial decrease in the
number of BFA-resistant colonies. This suggested that overexpression of
the clone 32 gene product is toxic and, to survive, cells must adjust expres-
sion of this protein to provide BFA resistance while avoiding its toxic ef-
fects; this would be accomplished by altering the ratio of these two plas-
mids by asymmetric segregation during cell division. Dilutions lower than
fivefold yielded fewer BFA-resistant transformants, presumably because
increasing numbers of cells were transformed with levels of clone 32 that
were immediately toxic. DNA sequencing was performed by primer walk-
ing on both strands using the ABI (Perkin-Elmer) sequencing kit. Ambi-
guities were resolved by standard dideoxy sequencing.
The transfections designed to test the enrichment of the BFA resis-
tance factor during selection were carried out essentially as described
above. Nearly confluent monolayers of 293 cells (2 
 
3
 
 10
 
7
 
 cells) were trans-
formed in triplicate and selection pressure was applied with 0.4 
 
m
 
M BFA
for 1 wk and the surviving cells were transferred to new plates at various
dilution ratios (1:2 to 1:100). After 1 wk of double selection in the pres-
ence of 0.3 mg/ml hygromycin B and 0.4 
 
m
 
M BFA, the hygromycin B con-
centration was gradually lowered by regularly exchanging half of the me-
dium volume with fresh medium lacking the drug. BFA was maintained at
0.4 
 
m
 
M. The number of surviving colonies was quantitated 2 wk later and
is presented 
 
6 
 
SD.
 
Cloning of GBF1 from Wild-type cDNA Library
 
Approximately 5 
 
3
 
 10
 
5 
 
clones from the CHO
 
pro-5
 
 cDNA library were dis-
played on LB plates and screened by colony hybridization using standard
techniques (Ausubel, 1997). The 
 
a
 
[
 
32
 
P]dCTP labeled, random primed
probe was generated using a Stratagene kit and the NheI-ScaI DNA frag-
ment of GBF1, encompassing the first 2 kb at the 5
 
9
 
 end of the cDNA.
Positive clones were characterized by Southern blotting (Ausubel, 1997)
of restriction digests followed by standard dideoxy sequencing of both
strands.
 
Production of (His)
 
6
 
-tagged GBF1
 
A GBF1 coding fragment was excised from pCEP4 by digestion with NotI
and SspI to yield a slightly truncated form of the gene missing the first five
codons. This fragment was ligated to the vector pEBVHis-C (Invitrogen)
that had been digested with XhoI (single polylinker site), filled in with
Klenow polymerase to produce blunt ends, and followed by digestion with
NotI. The resulting plasmid encodes an N-tagged (His)
 
6
 
-GBF1 containing
an additional 38 residues immediately preceding residue 6 of GBF1.
Transformation of 293 cells with this construct yielded BFA-resistant cells
at frequencies similar to those observed with the untagged version.
Detergent extracts were prepared as described above. Typically, 1–3 ml
of extracts (5–15 mg of protein) were incubated overnight at 4
 
8
 
C with 0.05 ml
of Ni-NTA resin (Qiagen) with gentle mixing. This slurry was packed on a
mini column and 0.25 ml fractions were collected by gravity throughout
the experiment. The column was first washed with 20-bed volumes of
buffer N (50 mM KHPO
 
4, pH 8.0, 300 mM NaCl, 1 mM PMSF) containing
15 mM imidazole. Elution was performed with buffer N supplemented
with 50 and 100 mM imidazole, using 20-bed volumes each time. The bulk
of tagged GBF1 typically eluted with 50 mM imidazole.
Production of (His)6-tagged Sec7 Domain of Sec7p
A DNA fragment containing the Sec7 domain encoding region (codons
827–1022) from the Sec7 gene of Saccharomyces cerevisiae was recovered
by PCR using pTA33-1 (Achstetter et al., 1988) as a DNA template, Pfu
DNA polymerase, and primers ySec7F 59-CGTAGGATCCAGGAA-
AACTGCTTTATCGGAA-39 and ySec7R 59-CGTAGAATTCTCAT-
TATGAAAGCATTGCCTGATGC-39. After 12 reaction cycles (958C/
1 min, 488C/50 s, 728C/1 min 45 s) and a final extension period at 728C for
4 min, the 0.6-kb fragment was digested with BamHI-EcoRI and sub-
cloned into the prokaryotic expression vector pRSET-A (Invitrogen). The
encoded product of 26 kD contained a hexahistidine sequence within the
NH2-terminal extension MRGSHHHHHHGMASMTGGQQMGRDLY-
DDDDKDRWGS. The construct was introduced into BL21DE3 pLYS-S
and recombinant protein induced and purified as described (Mansour et
al., 1999). Protein purity was unusually high (.90%) after Ni-NTA chro-
matography.
Measurement of GBF1-associated Guanine Nucleotide 
Exchange Activity on ARFs
The GTP exchange activity on ARF was measured as described (Paris
et al., 1997). Reactions (100 ml) contained 50 mM Hepes, pH 7.5, 1 mM
DTT, 1 mM or 1 mM of free Mg21 (1 mM MgCl2 and 2 mM EDTA), 1.5
mg/ml azolectin vesicles, 4 mM [35S]GTPgS (6,000 cpm/pmol), and 1 mM
ARF1/ARF3 (purified from bovine brain) or myristoylated recombinant
ARF5. Reactions received either BFA from the 10 mM stock or an equal
volume DMSO. Reactions were incubated at 378C and unless otherwise
indicated, aliquots (20 ml) were taken at 30 min. The results presented
have been corrected by subtracting background values measured in ab-
sence of ARFs and/or GBF1. The assay of the Sec7d fragment of Sec7p
was identical, except that it was carried out at 308C and in the presence of
myristoylated recombinant yeast ARF2 and 1 mM of free Mg21.
Cell Immunofluorescence
Wild-type CHO, BFY-1, and NRK cells grown to 60% confluency on fi-
bronectin-coated glass coverslips were fixed with 3.7% formaldehyde in
PBS for 20 min, permeabilized for 5 min with 0.1% Triton X-100 1 0.05%
SDS in PBS, and blocked with PBS 1 0.2% gelatin. Cells were single- or
double-stained by first incubating with optimal dilutions of m3A5 (anti–
b-COP) and/or anti-GBF1 serum (H154) followed by Texas red–conju-
gated donkey anti–rabbit and/or FITC-conjugated donkey anti–mouse an-
tibodies. 293 cells were processed identically, except that fixation was in
1:1 methanol/acetone for 5 min and incubated with antigiantin serum as
the primary antibody. The coverslips were mounted using 80% glycerol in
PBS and analyzed by standard epifluorescence using a Zeiss Axioscope
microscope. Confocal analysis was performed on a Leica Aristoplan con-
focal laser scanning microscope (CLSM facility, University of Alberta).
Images were processed for printing using Adobe Photoshop.
Immunoelectron Microscopy
Liver samples were prepared essentially as described previously (Dahan
et al., 1994). In brief, livers obtained from overnight-fasted male Sprague-
Dawley rats (100–125 g) were perfused first with saline and with a solution
of 4% paraformaldehyde/0.5% glutaraldehyde/0.1 M phosphate buffer,
pH 7.4, for 10 min. Small 1-mm3 pieces were dissected out and left in the
same fixative for another hour at 48C. Liver samples were washed four
times for 15 min with ice-cold 4% sucrose/0.1 M phosphate buffer, pH 7.4,
cryoprotected with several changes of 2.3 M sucrose/0.1 M phosphate
buffer (z1 h) (Tokuyasu, 1980), mounted on nickel stubs, and quick-fro-
zen in liquid N2. Cryosectioning of liver tissues samples was based on pub-
lished procedures (Tokuyasu, 1980; Geuze et al., 1984; Griffiths et al.,
1984) and was carried out as described in Dahan et al. (1994). 
The immunolabeling procedure consisted of incubating the sections on
drops of 0.02 M glycine in DPBS (137 mM NaCl, 2.7 mM KCl, 1.5 mM
KH2PO4, 6.5 mM Na2HPO4, 1 mM CaCl2, 0.5 mM MgCl2, pH 7.4) for 10
min followed by incubation on primary antibody for 30 min at room tem-
perature. Sections were washed 635 min in Dulbecco’s PBS (DPBS) fol-
lowed by blocking in DPBS-BCO (DPBS plus 2% BSA, 2% casein, and
0.5% ovalbumin) for 5 min and incubation in appropriate secondary anti-
bodies conjugated to gold particles for 30 min. Sections were washed six
times for 5 min in DPBS, six times for 5 min in H2O, stained for 5 min with
uranyl acetate–oxalate solution, pH 7.0, washed two times for 1.5 min in
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aqueous uranyl acetate for 10 min on ice. Grids were picked up with gold
loops and excess methyl cellulose was removed with filter paper. Antibod-
ies were diluted in DPBS-BCO as follows: 1:20 for mouse anti–b-COP, 1:5
for H133, 1:2 for H134, and 1:20 for all the secondary antibodies conju-
gated to colloidal gold. Controls where the primary antibodies were omit-
ted revealed negligible labeling (not shown). Sections were viewed in a
Philips 400 T electron microscope operating at 80 kV. 
Quantitation of gold particle labeling was essentially as described in
Dahan et al. (1994). Compartments of the secretory apparatus over which
gold particles were scored are defined in the legend of Table I. The inter-
twining nature of vesicular/tubular profiles prevented direct measurement
of membrane sectional profiles in tubule-rich areas. In this case, the sur-
face of the entire tubular region was employed, including some cytoplas-
mic space, which may have led to a minor underestimation of gold label-
ing density.
Results
To identify proteins implicated in the mechanism of action
of BFA, we used expression cloning to select cDNAs
whose production confers growth advantage in the pres-
ence of BFA. We chose to clone from a library prepared
from a highly BFA-resistant CHO cell line (BFY-1) to in-
crease the chances of success since such a selection could
yield either a mutant protein with altered BFA sensitivity
or a wild-type protein whose overexpression overcame the
effects of BFA. We expected to recover GBFs, since previ-
ous studies established that targets in this organelle were
most critical to the effects of BFA on growth (Yan et al.,
1994; Torii et al., 1995).
Identification of a cDNA Encoding a GBF
To recover GBF clones, we used an expression system
based on the episomal Epstein-Barr virus (EBV)-derived
vector, pCEP4, and its host cell line, 293-EBNA. This sys-
tem allows high frequency isolation of stable transfor-
mants that maintain expression vectors as episomes that
can subsequently be readily recovered for analysis. The
high sensitivity of 293 cells to BFA (LD50  , 0.07 mM;
Claude, A., and P. Melançon, unpublished observation)
makes them particularly appropriate hosts for the selec-
tion procedure.
Transformation of 293 cells under standardized condi-
tions with the BFY-1 cDNA library yielded stable trans-
formants able to grow in the presence of 0.2 mM BFA at a
frequency of z10 6 3 per 106 hygromycin-resistant trans-
formants, significantly higher than observed in parallel
transfections with empty vector. Transformation of pooled
plasmids recovered from BFA-resistant colonies grown
to confluence (enriched libraries) yielded BFA-resistant
transformants at a frequency of 1.4 3 103 6 0.2 per 106
hygromycin-resistant transformants, indicating a greater
than 100-fold enrichment in plasmids able to promote
BFA resistance (see Materials and Methods for details).
These results confirmed the presence of cDNAs encoding
GBFs in the BFY-1 library and demonstrated the effec-
tiveness of our selection method. Transformation with a
twice-selected library yielded a very large number of
BFA-resistant transformants (Fig. 1). Screening of 100
plasmids recovered from this library, first in pools then
singly, yielded clone 32. Its insert of 6.8-kb insert was des-
ignated GBF1 (Fig. 1; see Materials and Methods for de-
tails).
To determine whether the cDNA insert in clone 32, re-
named pCEP4-GBF1, is the most abundant or likely can-
didate for encoding a BFA resistance factor, several inde-
pendent BFA-resistant 293 colonies were isolated after
transformation with an enriched BFY-1 library. Four such
successfully expanded colonies yielded plasmid prepara-
tions that conferred BFA resistance; further analysis by re-
striction mapping, Southern blots, and colony hybridiza-
tion demonstrated that all four plasmid preparations were
similarly enriched (z1 in 45) in plasmids containing inserts
that hybridized with and had the same size and restriction
pattern as GBF1 cDNA (not shown). Furthermore, colony
hybridization of several independently enriched BFY-1 li-
braries demonstrated enrichment of the same cDNA to
frequencies also in the range of 1:30 to 1:60, the maximum
expected with this approach. These observations did not
result from a high abundance in GBF1 mRNA since
Southern and Northern blot analysis indicated that it was
relatively rare and present at ,1:100,000 copies in the
original libraries (not shown). We conclude that GBF1 is
the most likely candidate for a BFA resistance factor en-
coded in the BFY-1 cDNA library.
GBF Is a Novel 206-kD Protein Containing a
Sec7 Domain
Analysis of the predicted amino acid sequence (Fig. 2) re-
vealed a novel 206-kD protein with significant homology
to a family of proteins that contains a 170-residue domain,
called Sec7 domain (Sec7d), first identified in the secretion
protein Sec7p of S. cerevisiae. This homology is significant
since many Sec7 domain–containing proteins have been
implicated in ARF guanine nucleotide exchange (Chardin
et al., 1996; Peyroche et al., 1996; Meacci et al., 1997). Fur-
thermore, the Sec7d itself has been shown to possess an in-
trinsic ARF-GEF activity (Chardin et al., 1996; Morinaga
et al., 1997; Sata et al., 1998; Mansour et al., 1999).
The Sec7d of GBF1, highlighted in Fig. 2 A, displays an
identity ranging from 38 to 45% with that of the other
members and carries the two canonical motifs (boxed).
More importantly, it contains the conserved glutamate of
motif 1 (FRLPGEAPVI) recently implicated in the GEF
activity of ARNO (Beraud-Dufour et al., 1998; Goldberg,
1998). Multiple alignment of GBF1 with key members of
this family showed most extensive similarity with the two
yeast proteins, Gea1p and Gea2p (Fig. 2 B). In addition to
the defining central Sec7d, these proteins share eight re-
gions ranging from 23–38% and 44–64% in extent of iden-
tity and similarity, respectively. In contrast, p200 and
Sec7p share only five and three of these regions with
GBF1, respectively, and, thus, appear to fall in a separate
class. Small proteins of this family, such as ARNO only
share the Sec7d. Further analysis of GBF1 with computer
prediction programs did not reveal additional salient fea-
tures other than a hydrophobic segment between residues
1,633–1,651 and a proline-rich region at the COOH termi-
nus starting at residue 1,778.
Overexpression of GBF1 Confers BFA Resistance Both 
In Vivo and In Vitro
To determine if the growth advantage resulting from
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complex, we tested the effect of BFA on the distribution
of Golgi markers in control and GBF1-expressing cells.
Such stable GBF1 transformants grew at BFA concentra-
tions 10–15-fold higher than control transformants con-
taining empty vector and maintained this level of resis-
tance for at least 4 mo of continuous culture. Giantin, a
well characterized Golgi complex marker (Linstedt and
Hauri, 1993) was used to evaluate the morphology of
GBF1 transformed cells. As shown in Fig. 3, expression of
GBF1 allowed cells to maintain the characteristic perinu-
clear localization of their Golgi complex in the presence of
4 mM BFA, a concentration that led to complete dispersal
in control cells.
It has been previously reported that BFA inhibits ARF
activation and coat recruitment both in vivo and in vitro,
indicating that BFA acts at or upstream of the ARF
guanine nucleotide exchange activity (Donaldson et al.,
1992b; Helms and Rothman, 1992; Randazzo et al., 1993).
To test whether GBF1 acts at this level, we used cell-free
assays that measure membrane-associated ARF-GEF ac-
Figure 1. Isolation of a cDNA clone that allows cell growth in the presence of BFA. 293 cells were transformed as described in Materi-
als and Methods with pCEP4 (empty vector), a twice-enriched BFY1 cDNA library, a pool of 33 plasmids derived from the twice-
enriched cDNA library, clone 10 and clone 32 (both included in the pool of 33 plasmids). Transformants were selected and grown in the
presence of 0.4 mM (0.1 mg/ml) BFA for 6 d. Cell growth was scored by light microscopy and photographs were taken at the indicated
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tivity and recruitment of COPI. Golgi-enriched membrane
fractions were prepared from either control or GBF1-
expressing 293 cells. GEF assays performed with native
ARFs obtained from bovine brain (predominantly ARF3)
established that Golgi-enriched membrane fractions pre-
pared from 293/GBF1 cells displayed normal levels of
ARF-GEF activity (Fig. 4 A). However, in contrast to that
observed with control membranes, this activity was com-
pletely resistant to BFA. To establish whether the BFA-
resistant ARF-GEF activity was relevant to coatomer re-
cruitment, we compared the ability of 293 and 293/GBF1
membranes to recruit COPI components. As observed
with the nucleotide exchange assay, 293/GBF1 membranes
recruited levels of COPI nearly identical to those mea-
sured with control membranes (Fig. 4 B). Furthermore,
COPI recruitment on these membranes was barely af-
fected at a BFA concentration as high as 70 mM when re-
cruitment to control membranes was inhibited by .50%
at 7 mM BFA (Fig. 4 B).
To measure the extent of GBF1 overexpression and as-
sess its distribution, we prepared and characterized several
antisera raised against a peptide corresponding to the
COOH terminus of GBF1 (see Materials and Methods).
These antisera recognized specifically a protein of 206 kD
in both CHO and 293 cells, a size similar to that predicted
from the sequence of the cDNA (Fig. 5 A and data not
shown). BFA-resistant 293 transformants overexpressed
GBF1 six- to eightfold above the endogenous protein level
(Fig. 5 A, right). As predicted, the majority of overex-
pressed GBF1 in 293/GBF1 cells was recovered in cytoso-
lic extracts under conditions where microsomes were effi-
ciently removed as established with the membrane protein
calnexin (Fig. 5 B). Endogenous GBF1 in BFY-1 cells also
partitioned primarily to the cytosol (Fig. 5 C); quantitation
of this and similar experiments established that only a
small fraction (, 10%) of endogenous protein was recov-
ered in the microsome pellet. Similar results were ob-
tained for the endogenous protein in wild-type 293 and
Figure 2. GBF1 is a novel member of the Sec7 family of proteins.
(A) Deduced amino acid sequence of GBF1. The Sec7 domain of
this protein (170 amino acids) is indicated in bold characters. The
two highly conserved motif 1 and motif 2 within this domain are
surrounded by boxes. The sequence data are available from Gen-
Bank/EMBL/DDBJ under accession number AF127523. (B)
Multiple alignment of GBF1 and other key members of the Sec7
family of proteins generated with the MACAW program. The
name of each protein is indicated on the left of each peptide dia-
gram. The number of amino acid residues is indicated on the
right. Boxes indicate regions of significant homology among two
or more proteins. Darker shading of homology boxes indicates
increased representation of these domains across family mem-
bers. Small members of the family are represented by the better
characterized ARNO.
Figure 3. The Golgi morphology of 293 overexpressing GBF1 is
resistant to BFA. 293 cells were transformed as described with
pCEP4 vector (control) or pCEP4-GBF1 (GBF1) and grown on
coverslips. The cells were incubated in the absence (A and B) or
in the presence of 4 mM BFA (C and D) for 20 min before fixa-
tion and staining with antigiantin serum as described in Materials
and Methods. Bar, 10 mm.The Journal of Cell Biology, Volume 146, 1999 78
CHO cells (not shown). Our observations suggest that
GBF1 is a primarily soluble protein implicated in coato-
mer recruitment.
GBF1 Is a BFA-resistant ARF-GEF
To confirm that GBF1 had ARF-GEF activity and deter-
mine whether this activity was sensitive to BFA, we modi-
fied GBF1 with a hexahistidine tag to facilitate its purifica-
tion. Control transfection experiments established that
tagging did not reduce the ability of GBF1 to cause BFA
resistance (not shown). A significant fraction of GBF1
from detergent extracts of (His)6-GBF1 transformants
bound Ni-NTA columns and eluted at a 50 mM imidazole
concentration (not shown). In contrast, endogenous GBF1
in extracts from control cells remained in the flowthrough
fraction. At 1 mM of free Mg21, eluate fractions containing
tagged-GBF1 stimulated binding of GTP on native ARFs
from the bovine brain (1:9 mixture of ARF1 and ARF3),
whereas those from control cells showed no activity (Fig. 6
A). This GEF activity appears specific for small GTPases
of the ARF family since no such stimulation was observed
with purified Sar1p or rab1b (Fig. 6 A). The GEF activity
observed on ARF1/3 is significant and clearly above the
spontaneous loading observed with ARF alone. This back-
ground was much lower than previously reported by Paris
et al. (1997) for recombinant myristoylated ARF1 that in-
dicates that ARF3 spontaneously binds GTP at a much
lower rate than ARF1 at low Mg21 concentrations.
As predicted from the studies with Golgi-enriched frac-
tions in Fig. 4, the GEF activity of GBF1 towards ARF1/3
is completely resistant to BFA under these conditions. Ad-
dition of 360 mM BFA to exchange assays caused no re-
duction in nucleotide exchange (Fig. 6 B). As a positive
control to establish the activity of our BFA in in vitro ex-
change assays, we constructed, purified, and tested a 36-kD
recombinant protein containing the Sec7 domain of Sec7p.
Such a truncated protein was previously shown to have
BFA-sensitive ARF-GEF activity (Sata et al., 1998). BFA
caused dose-dependent inhibition of our recombinant pro-
tein (Fig. 6 C), therefore, confirming the BFA-resistant
nature of GBF1 observed in Fig. 6 B.
Figure 4. ARF-GEF and
COPI recruitment activity on
Golgi membranes from cells
expressing GBF1 is resistant
to BFA. (A) Identical
amounts (4.2 mg) of Golgi-
enriched membrane fractions
from 293 cells or 293 cells
transformed with GBF1 were
assayed for ARF nucleotide
exchange in the presence of
a[32P]GTP and in the ab-
sence or presence of BFA
(280 mM). Each bar repre-
sents the average of three de-
terminations  6  SD. Similar
results were obtained with
several independently ob-
tained membrane prepara-
tions. (B) Coatomer recruit-
ment assays contained Golgi
membranes prepared from
293 cells transformed with ei-
ther pCEP4 (open circle) or
pCEP4-GBF1 (closed circle)
and the indicated amounts of
BFA. The extent of recruitment of COPI provided by BFA-sen-
sitive cytosol was determined in triplicate as described in Materi-
als and Methods. The results 6 SD are plotted as a function of
BFA concentration. Similar results were obtained with several
different membrane preparations.
Figure 5. The anti–C-tail peptide antibody detects a 206-kD pro-
tein consistent with the predicted size of GBF1. (A) Serum H154
recognizes a 206-kD protein that is expressed at normal levels in
mutant BFY-1 cells but is overexpressed in 293 cells transfected
with pCEP4-GBF1. Identical amounts of Triton X-100 extracts
(30 mg) from the indicated cell lines were analyzed by PAGE/im-
munoblotting as described in Materials and Methods. Blots were
incubated with the indicated sera and processed for enhanced
chemifluorescence. Scans obtained with a PhosphorImager in flu-
orescence mode are shown. The size of molecular weight stan-
dards run in parallel are indicated. (B) GBF1 is primarily cytoso-
lic when overexpressed in 293/GBF1 cells. Identical amount (90 mg)
of postnuclear supernatants from the indicated cells were ana-
lyzed by PAGE/immunoblotting either directly or after separa-
tion into cytosol and membrane fractions by ultracentrifugation
as described in Materials and Methods. Blots were incubated
with H154 anti-GBF1 serum and anticalnexin antibodies before
processing for enhanced chemifluorescence. The distribution of
the membrane protein calnexin confirms the absence of mi-
crosomes in the cytosol and their recovery in the pellet fraction.
(C) GBF1 is primarily cytosolic in BFY-1 cells. The fractionation
and detection were as described for B.Claude et al. Expression Cloning of BFA Resistance Factor 79
The initial characterization of GBF1 was performed at
low Mg21concentrations because its GEF activity towards
ARF1/3 appeared to be very poor at the higher and more
physiological Mg21concentration of 1 mM. Further analy-
sis revealed that this resulted not from an overall weak ac-
tivity but rather from its specificity towards group II
ARFs. As shown, in Fig. 6 D, GBF1 effectively promoted
GTP loading on ARF5 but remained inactive on ARF1/3
at physiological Mg21 concentration. Importantly, this
GEF activity of GBF1 was fully resistant to 600 mM BFA.
Consistent with the proposed ARF5-GEF activity of
GBF1, neither control extracts nor heat-treated GBF1
fractions (Fig. 6 D, asterisk) stimulated GTP binding. Note
that although moderate, the extent of ARF loading ob-
served here was comparable to that previously reported
for other large ARF-GEFs (Peyroche et al., 1996; Mori-
naga et al., 1997; Mansour et al., 1999).
Wild-type Form of GBF1 Is a Naturally
Resistant ARF-GEF
To determine whether GBF1 recovered from the BFY-1
library was a mutant allele, we isolated cDNAs from a li-
brary prepared from the wild-type parental CHO line by
colony hybridization. Sequencing revealed that full length
cDNAs recovered from the wild-type library had se-
quences identical to GBF1. Deletions of 3 and 12 nucle-
otides were observed at positions 1,864 and 4,479, respec-
tively (Fig. 7 A), and reverse transcriptase–PCR analysis
of mRNA prepared from both BFY-1 and parental CHO
cells established that transcripts with and without those
deletions were present at identical frequencies in both mu-
tant and wild-type lines (not shown). Those probably
arose by alternative processing. Furthermore, cDNAs
identical in sequence to that shown in Fig. 7 A were recov-
ered by colony hybridization of a twice selected BFY-1
cDNA library. The fact that GBF1 transcripts with identi-
cal sequences were recovered from wild-type and BFY-1
cells indicate that wild-type GBF1 is naturally BFA resis-
tant. As expected, transfection of the wild-type cDNA dia-
grammed in Fig. 7 A led to recovery of BFA-resistant
transformants (Table I). The human orthologue of GBF1
(Mansour et al., 1998) similarly caused BFA resistance
when overexpressed (Melançon, P., unpublished observa-
tions).
The previous results established that BFA resistance in
BFY-1 cells did not arise by mutation of GBF1. To test
whether BFY-1 became resistant to BFA by overexpress-
ing this BFA-resistant GEF, several independent Triton
X-100 extracts were obtained from the wild-type parental
and BFY-1 cell lines and analyzed for GBF1 content by
immunoblots. Lanes loaded with equal amounts of pro-
tein, as confirmed with the cytosolic marker glucose-
6-phosphate dehydrogenase (G6PDH), contained nearly
identical levels of GBF1 (Fig. 7 B). Multiple quantitation
of several independent extracts from these lines showed
that endogenous GBF1 levels in those lines were within
10% of each other. This observation ruled out overexpres-
sion of GBF1 as the mechanism of resistance in BFY-1 cells.
Figure 6. (His)6-GBF1 is a BFA-resistant ARF-GEF. (A) Frac-
tions enriched in (His)6-GBF1 display a GEF specific for ARFs.
Identical volumes (5 ml) of the 50 mM imidazole eluate fractions
from the control (vector alone) and (His)6GBF1 extracts were as-
sayed for loading of small GTPases with GTPgS in 1 mM of free
Mg21 as described in Materials and Methods. Purified ARF1/3,
Sar1p, or rab1b (1 mM each) were used as substrate as indicated.
Each bar represents the average of three determinations 6 SD.
(B) GEF activity of GBF1 towards ARF1/3 is BFA resistant.
Time course of ARF1/3 nucleotide exchange using the 50 mM
imidazole eluate fraction from the (His)6GBF1 extracts. Assays
were performed at 1 mM of free Mg21 either in the presence
(closed circle) or absence (open circle) of BFA (360 mM). Similar
results were obtained with several independent preparations. (C)
The purified Sec7 domain of Sec7 is a BFA-sensitive ARF-GEF.
Assays were performed as described in Materials and Methods
with the indicated amounts of BFA. Each bar represents the av-
erage of three determinations 6 SD. (D) GBF1 is a BFA-resis-
tant GEF specific for ARF5 at 1 mM Mg21. Identical volumes
(5 ml) of the 50 mM imidazole eluate fractions from the control
(empty vector) and (His)6GBF1 extracts were assayed for load-
ing of ARF1/3 or ARF5 in assays containing 1 mM Mg21. BFA
was used at a concentration of 600 mM. One set of reactions was
performed with the GBF1 fraction inactivated (asterisk) by incu-
bation at 958C for 5 min. Each bar represents the average of three
determinations 6 SD.
Table I. Expression of GBF1 cDNAs Recovered from Both 
BFY-1 and Wild-type CHO Cells Confers Resistance to BFA
Plasmid transfected Percent BFA-resistant cells*
pCEP4 3 6 1.2
pCEP4-GBF1 60 6 2
pCEP4-GBF1WT 64 6 12
*293 cells were transformed with empty vector (pCEP4), the plasmid first recovered
from the BFY-1 cDNA library (pCEP4-GBF1) and a plasmid recovered from the
wild-type cDNA library illustrated in Fig. 7 A (pCEP4-GBF1WT). An equal number of
hygromycin B–resistant cells were plated in the presence of 0.4 mM BFA and incu-
bated for 3 d. Surviving cells were trypsinized and counted. The results 6 SD are pre-
sented as a percentage of hygromycin B–resistant transformants that are BFA resis-
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GBF1 Colocalizes with b-COP to the Golgi Complex
The observation that GBF1 is a BFA-resistant ARF-GEF
whose expression allows BFA-resistant recruitment of the
COPI coat onto Golgi membranes strongly implicates it in
protein traffic at the Golgi complex. To determine if
GBF1 associates with the Golgi complex in vivo, we exam-
ined its intracellular distribution in CHO and NRK cells
using indirect immunofluorescence with the H154 antiserum
(Fig. 8).
The images shown in Fig. 8 A revealed significant cyto-
solic staining accompanied with clear localization to a
perinuclear structure reminiscent of the Golgi complex.
As expected from the similar levels of expression and dis-
tribution between membrane and cytosol fractions of wild-
type CHO and BFY-1 cells, comparable distribution was
observed in these two cell lines. In the flatter NRK cells
with better morphology, GBF1 stained a tight ribbonlike
perinuclear structure, characteristic of the Golgi complex
in these cells (Fig. 8 A, right). To confirm the link between
GBF1 and COPI, we examined by confocal microscopy
the intracellular distribution of these two proteins in NRK
cells stained simultaneously with H154 and m3A5, a well
characterized antibody that recognizes the b-subunit of
COPI (Fig. 8 B). The extensive overlap in the distribution
of endogenous GBF1 and b-COP shown by the merged
image in the center confirms that the primary site of mem-
brane recruitment in the cell is the Golgi complex.
More detailed subcellular localization of GBF1 was ob-
tained by immunoelectron microscopy. Immunolabeling
of liver ultrathin cryosections was performed with several
sera raised against the COOH-terminal peptide of GBF1.
All sera showed similar staining of tubular elements adja-
cent to Golgi stacks (Fig. 9, A and B, brackets and ar-
rows). These elements correspond to the regions of great-
est antigenicity of COPI in rat liver sections (Fig. 9, C and
Figure 7. GBF1 is a naturally BFA-resistant GEF that is not
overexpressed in BFY-1 cells. (A) Schematic representation of
the GBF1 allele identified in wild-type CHO cells. The position
of the Sec7d is indicated by the dark rectangle and the deletions
by thin vertical lines. The size of the deletions and the position of
the last nucleotide before each deletion are indicated above and
below, respectively. These in frame deletions lead to the loss of S
(622) and VSQD (1494-1497), respectively. (B) GBF1 is ex-
pressed at similar levels in wild-type CHO and mutant BFY-1
cell lines. Identical amounts of Triton X-100 extracts (30 mg)
from the indicated cell lines were analyzed by PAGE/immuno-
blotting as described in Materials and Methods. Blots were incu-
bated with H154 anti-GBF1 and anti-G6PDH antibodies. The ra-
tios of GBF1 to G6PDH were identical in both extracts.
Figure 8. GBF1 colocalizes with
b-COP to the Golgi complex. (A)
Wild-type CHO (left), mutant BFY-1
(center), and NRK (right) cells were
permeabilized and incubated with
rabbit serum H154 (anti-GBF1) and
stained with a Texas red–conjugated
secondary antibody. Images obtained
by standard epifluorescence micros-
copy are presented. (B) NRK cells
were permeabilized and incubated
with rabbit serum H154 (anti-GBF1)
and mAb m3A5 (anti–b-COP) and
stained with FITC- (b-COP) and Texas
red– (GBF1) conjugated secondary
antibodies. The images presented
were obtained by confocal micros-
copy. (Left) GBF1 signal; (right)
b-COP signal; and (center) merge of
both images. Bars, 10 mm.Claude et al. Expression Cloning of BFA Resistance Factor 81
D; Dahan, S., and J.J.M. Bergeron, unpublished observa-
tions). Significant labeling was also observed over Golgi
stacks, particularly at the electron lucent distensions
(curved arrows), and on ER cisternae (arrowheads). Little
staining of mitochondria and peroxisomes was observed
under these conditions. Quantitative analysis of the GBF1
labeling experiments confirmed that even though a signifi-
cant amount of GBF1 staining localized to peripheral tu-
bules, the greatest concentration occurred in the Golgi re-
gion (Table II).
Discussion
An expression cloning strategy designed to identify pro-
teins that promote Golgi-specific resistance to BFA, yielded
a single cDNA from a library prepared from a highly
BFA-resistant CHO mutant line. This cDNA encodes a
novel 206-kD Sec7 domain protein, termed GBF1, that is
primarily cytosolic and displays ARF-specific and BFA-
resistant GEF activity. This protein localizes to the Golgi
complex, displays specificity towards ARF5, and is a strong
candidate for a GEF involved in regulating ARF activation
for transport within the early secretory pathway.
Identification of a Novel BFA-resistant ARF-GEF
GBF1 was identified as a resistance factor that allowed
growth in the presence of BFA. This activity appears dom-
inant as cells transfected with the cDNA grew in the pres-
ence of BFA, and Golgi membranes recovered from these
cells activated ARFs and recruited COPI in a BFA-resis-
tant manner. As expected from the presence of a Sec7 do-
main, GBF1 displayed guanine nucleotide exchange activ-
ity that was clearly BFA resistant. Under physiological
conditions, GBF1 appeared specific towards Group II
ARFs since it exhibited clear GEF activity on ARF5 and
Figure 9. GBF1 localizes primarily to a tubular network proximal to Golgi stacks. Rat liver frozen cryosections were processed, labeled,
and photographed as described in Materials and Methods. (A) anti-GBF1 serum H134 (diluted 1:2). (B) anti-GBF1 serum H133 (di-
luted 1:5). (C and D) mouse anti–b-COP (diluted 1:20). (Arrowheads) Gold particles labeling ER cisternae. (Arrows) Gold particles la-
beling tubular networks proximal to the Golgi complex. (Curved arrows) Gold particles labeling Golgi stacks. (Brackets) High concen-
tration of gold particles labeling tubular networks proximal to the Golgi complex. M, mitochondria; P, peroxisome; and G, Golgi stack.
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much less towards ARF1/3. Although the role of ARF5
in protein transport and secretion remains unknown, it
clearly associates with Golgi structures (Tsai et al., 1992)
and this interaction is largely BFA resistant (Tsai et al.,
1993). This BFA-resistant binding of ARF5 to Golgi mem-
branes is consistent with the properties of GBF1 and fur-
ther experiments will clarify the relationship between
ARF5, GBF1, and the secretory pathway.
The sequence of the GBF1 Sec7d is not inconsistent
with the observed BFA resistance of the GEF activity.
Several recent reports demonstrate that Sec7d is a direct
target of BFA since purified Sec7d from multiple proteins
display an ARF-GEF activity that is BFA sensitive (Sata
et al., 1998; Mansour et al., 1999; Peyroche et al., 1999).
Analysis of the Sec7d sequence of a variety of proteins has
recently established that variation on two key amino acids
within motif 2 of this domain correlates with the BFA sen-
sitivity of each family member (Peyroche et al., 1999). The
consensus motif for BFA-sensitive proteins is LSYSI-
IMLNTDL and that for BFA-resistant proteins is LSFAI-
IMLNTSL. Mutation of FA to YS is sufficient to convert
the ARF-GEF activity of the Sec7 domain of ARNO from
BFA resistant to BFA sensitive. The fact that motif 2 of
GBF1 displays a hybrid sequence (LAYAVIMLNTDQ;
Fig. 3 A) and contains three additional amino acids
(NVP), eight residues downstream of motif 2 relative to
the consensus sequence, may account for the BFA resis-
tance and ARF specificity of this protein.
Since all previously characterized large Sec7d proteins
display BFA-sensitive GEF activity (Peyroche et al., 1996;
Morinaga et al., 1997), we expected the BFA resistance of
GBF1 to result from mutation of a wild-type BFA-sensi-
tive GEF. However, cloning of GBF1 cDNAs from wild-
type CHO cells and further characterization of BFY-1
transcripts established that processing variants in those
two lines have identical sequences. Furthermore, transfec-
tion of GBF1 cDNAs recovered from the wild-type library
promoted growth in the presence of BFA. The BFA-resis-
tant phenotype caused by GBF1 in transformed 293 cells
must, therefore, result from overexpression of a naturally
BFA-resistant protein. The observation that GBF1 levels
were identical in the parental CHO and mutant BFY-1
lines, indicated that resistance in the mutant line arose
from changes in a different gene product such as BFA-sen-
sitive GBF or p200 isoforms. Our inability to identify the
BFY-1 resistance factor could have resulted from the fact
that this protein is part of a complex or that its cDNA is
present at very low levels in the library. Alternatively, re-
sistance in BFY cells could have arisen from mutations in
more than one gene. Ongoing analysis of our BFA-resis-
tant lines should elucidate the resistance mechanism.
GBF1 Is a Strong Candidate for a Regulator of
ARF Activation during Traffic through the Early 
Exocytic Pathway 
GBF1 manifests many of the properties of an ARF-GEF
implicated in recruitment of COPI for traffic within the
early exocytic pathway. First, transfection with its cDNA
yielded Golgi membranes displaying normal levels of
GBF1 and ARF-GEF activity that recruited COPI in a
BFA-resistant manner. In addition, as expected of such an
ARF-GEF, it colocalized with COPI to the Golgi complex
and smooth tubules that may correspond to traffic inter-
mediates between the ER and Golgi complex. Finally, the
fact that its sequence is most similar to that of Gea1p/
Gea2p further supports this model. Overexpression of ei-
ther of these proteins, but not that of Sec7p, was found to
suppress the dominant-negative effects of an ARF1 mu-
tant that has reduced nucleotide binding capacity and is
thought to block growth by sequestering its GEF (Pey-
roche, 1996).
The present experimental evidence is insufficient to de-
fine the exact role of GBF1 since it does not reveal in
which direction of transport this GEF functions. The fact
that BFA blocks anterograde traffic suggests that GBF1
does not normally function as the primary GEF responsi-
ble for coat recruitment for anterograde traffic. However,
since retrograde traffic from the Golgi is not blocked by
BFA, the naturally BFA-resistant GBF1 may well func-
tion primarily in that direction. Our results indicate that
the overlap in function between GBF1 and the BFA-sensi-
tive GEF involved in anterograde traffic is, nevertheless,
sufficient to allow BFA-resistant forward traffic when
GBF1 is overexpressed. This could occur by partially dis-
placing the BFA-sensitive GEF, possibly p200 (Mansour
et al., 1999), which normally regulates this process. This
displacement of the normal GEF by GBF1 would explain
the cytotoxicity resulting from gross overexpression after
transfection of undiluted pCEP4-GBF1 (see Materials and
Methods).
In contrast to Sec12p, the membrane-associated GEF
for Sar1p responsible for COPII recruitment (Barlowe et al.,
1994), GBF1 is primarily soluble. This suggests that this
GEF is recruited only when and where needed to initiate
budding. Such a regulated recruitment mechanism for a
retrograde-specific GEF may be necessary if Golgi cister-
nae were not stable structures, but rather were constantly
remodeled during the cisternal progression for which ex-
perimental evidence has been accumulating (Bonfanti et al.,
1998; Glick and Malhotra, 1998). The observation that
normal levels of GBF1 and ARF-GEF activity were asso-
ciated with Golgi membranes despite a five- to eightfold
overexpression indicates that the number of recruitment
Table II. Labeling Density Distribution of GBF1
Compartment examined Percent gold labeling Labeling density
gold/mm2
Golgi-stacked saccules 27.7 6.7
Golgi-associated tubules* 17.7 3.1
Distal tubules‡ 38.3 3.2
Rough ER cisternae 16.2 2.5
35 micrographs of Golgi regions from ultrathin cryosections of rat liver immunola-
beled with anti-GBF1 antibody (H133 diluted 1:5) followed by goat anti–rabbit IgG-
10 nm gold were analyzed for the gold particle density in the indicated compartments.
Only gold particles within 20 nm of a membrane profile were scored. Percentage gold
particle labeling values represent the number of gold particles over respective com-
partments expressed as a fraction of the total number of gold particles (912) scored in
the four secretory apparatus compartments examined. Labeling density values were
obtained by scoring the total number of gold particles in a given compartment and di-
viding by the total profile area of that compartment. Mitochondrial and peroxisomal
labeling density (2.0 gold particles/mm2) in the same micrographs were used as an in-
dicator of background labeling and were subtracted to yield the values presented.
*Includes tubular and vesicular profiles within 750 nm of a Golgi stack.
‡Includes tubule profiles at least 750 nm away from Golgi stacks. Claude et al. Expression Cloning of BFA Resistance Factor 83
sites may be limited. In such a model of GBF1 action
membrane recruitment would most likely be accompanied
by GEF activation.
Sec7d Proteins: A Family of ARF-GEFs?
The Sec7d family can be broadly separated in three classes
that may have distinct but related functions. The highly
similar small members (z50 kD) were represented in Fig.
2 B by the better characterized ARNO protein. The larger
and more heterogeneous members (160–210 kD), all listed
in that figure, can be divided into two classes. Sequence
comparison identified up to 14 regions of highly conserved
sequence outside the defining Sec7 domain. The small
ARNO-like proteins contain only the Sec7d and constitute
a class of their own. As shown in Fig. 2 B, GBF1, Gea1/2,
and to a lesser extent EMB30 can be grouped in a class
based on the number of shared domains. Sec7 and p200
form an apparently distinct group by default based on
their low number of shared domains. At present it is not
clear whether these two proteins will give rise to separate
subclasses, but it is likely that this preliminary classifica-
tion will be refined as more members and/or isoforms of
the Sec7d family are discovered in higher eukaryotes.
The specific functions of various members of this family
in protein traffic are likely determined by their specificity
towards various ARFs and the intracellular membranes to
which they are recruited. For example, small members of
this family such as ARNO localize to the endosomal com-
partment and appear specific for ARF6 (Frank et al.,
1998). It is interesting to note that these small Sec7d pro-
teins all contain a pleckstrin homology domain. Such do-
mains bind phosphoinositides (Harlan et al., 1995; Rebec-
chi and Scarlata, 1998) and facilitate recruitment of the
GEF to the membrane where it can act more effectively
on its membrane-associated substrate (Chardin, 1996).
The large members of the family lack this domain and may
utilize a more complex mechanism to regulate membrane
association through their additional domains. Interest-
ingly, the various Sec7d proteins, being potential targets
for BFA, could constitute the multiple organelle specific
targets whose existence was suggested by earlier studies.
GBF1 and p200 both localize to the Golgi complex (this
work and Mansour et al., 1999) and mutations in their
orthologues Gea1p/Gea2p and Sec7p were found to inter-
fere with protein secretion (Achstetter et al., 1988; Pey-
roche et al., 1999). Both classes of large Sec7d proteins
are, therefore, implicated in the exocytic pathway. Our
demonstration that these two classes of ARF-GEF may
act on groups I and II ARFs selectively and, thus, have dis-
tinct specialized functions may provide a mechanism to ex-
plain how COPI could be involved in both anterograde
and retrograde traffic. Further studies on GBF1 and p200
and the proteins with which they associate are certain to
shed more light on these somewhat contradictory roles of
ARF and COPI in movement of proteins to and from the
Golgi complex.
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